Phil Skolnick
Officer at Opiant Pharmaceuticals, Inc. (OPNT)
Phil Skolnick has filed 10 insider reports with the SEC since January 2021, as officer at Opiant Pharmaceuticals, Inc. (OPNT). Phil Skolnick made no open-market purchases or sales in the last 12 months. The latest filing, on March 3, 2023, reports grant or award and sale back to the company at Opiant Pharmaceuticals, Inc. (OPNT).
- Filings
- 10
- Companies
- 1
- Bought on market
- None
- Sold on market
- $105K
Companies where Phil Skolnick is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 0 | $105K | Mar 3, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 2, 2023OPNTSEC Form 4: Skolnick Phil returned $470,960 worth of shares to the company (23,548 units at $20.00) and was granted 2,000 shares, closing all direct ownership in the companyForm 4Grant or awardSale back to the company
- Jan 27, 2023-$9,725OPNTSEC Form 4: Skolnick Phil sold $9,725 worth of shares (480 units at $20.26), decreasing direct ownership by 2% to 21,548 units to satisfy withholding taxForm 4Open-market sale
- Jan 9, 2023-$7,454OPNTSEC Form 4: Skolnick Phil sold $7,454 worth of shares (369 units at $20.20), decreasing direct ownership by 2% to 22,028 units (for tax liability)Form 4Open-market sale
- Jan 5, 2023-$28.7KOPNTSEC Form 4: Skolnick Phil sold $28,704 worth of shares (1,421 units at $20.20), decreasing direct ownership by 6% to 22,397 units (for tax liability)Form 4Open-market sale
- Jul 14, 2022-$7,430OPNTSEC Form 4: Skolnick Phil sold $7,430 worth of shares (627 units at $11.85), decreasing direct ownership by 3% to 23,818 units to satisfy withholding taxForm 4Open-market sale
- Jun 27, 2022OPNTSEC Form 4: Skolnick Phil was granted 2,000 shares, increasing direct ownership by 9% to 24,445 unitsForm 4Grant or award
- Jan 27, 2022-$39.8KOPNTSEC Form 4: Skolnick Phil sold $39,756 worth of shares (1,518 units at $26.19), decreasing direct ownership by 6% to 22,445 units to satisfy withholding taxForm 4Open-market sale
- Jan 10, 2022-$11.7KOPNTSEC Form 4: Skolnick Phil sold $11,739 worth of shares (385 units at $30.49), decreasing direct ownership by 2% to 23,963 units (withholding obligation)Form 4Open-market sale
- Jan 4, 2022OPNTSEC Form 4: Skolnick Phil was granted 12,000 shares, increasing direct ownership by 97% to 24,348 unitsForm 4Grant or award
- Jan 26, 2021OPNTSEC Form 4: Phil Skolnick was granted 8,198 units of Common Stock, increasing ownership by 198% to 12,348 unitsForm 4Grant or award
Compare Phil Skolnick with
- Phil Skolnick vs Gabrielle Alison Silver1 shared
- Phil Skolnick vs Craig A Collard1 shared
- Phil Skolnick vs Matthew R. Ruth1 shared
- Phil Skolnick vs Richard J Daly1 shared
- Phil Skolnick vs Roger Crystal1 shared
- Phil Skolnick vs Ellison Mark Jason Heath1 shared
Questions about Phil Skolnick
- What is Phil Skolnick's role at Opiant Pharmaceuticals, Inc.?
- Phil Skolnick reports to the SEC as officer at Opiant Pharmaceuticals, Inc. (OPNT), according to the latest filing on March 3, 2023.
- Has Phil Skolnick bought or sold stock recently?
- The most recent open-market sale was on January 27, 2023: sold 480 shares of Opiant Pharmaceuticals, Inc. (OPNT) for $9,725 at an average of $20.26.
- How do I get alerts when Phil Skolnick files?
- Follow Phil Skolnick on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Phil Skolnick (SEC CIK 0001358116). Totals count each trade once, skipping amendments whose original is on file, from Jan 27, 2021 on. View on SEC EDGAR · Get this as JSON